Cervoni P et al. |
Evidence for the lack of interaction between (+/-)-1-O-octadecyl-2-acetylglyceryl-3-phosphorylcholine and alpha-adrenoceptors in vivo and in vitro. |
1984 |
Br. J. Pharmacol. |
pmid:6091835
|
Mendlovic F et al. |
Possible involvement of cyclooxygenase products in the actions of platelet-activating factor and of lipoxygenase products in the vascular effects of epinephrine in perfused rat liver. |
1984 |
Biochem. Biophys. Res. Commun. |
pmid:6435614
|
Fouque F and Vargaftig BB |
Triggering by Paf-acether and adrenaline of cyclo-oxygenase-independent platelet aggregation. |
1984 |
Br. J. Pharmacol. |
pmid:6439269
|
Karlsson G and Pipkorn U |
Effect of disodium chromoglycate on changes in nasal airway resistance induced by platelet activating factor. |
1984 |
Eur. J. Clin. Pharmacol. |
pmid:6439565
|
Sänze JU et al. |
On the nature of the vasoreactivity depressing factor (VDF) in inflammation and anaphylaxis in the rat and mouse. |
1984 |
Biomed. Biochim. Acta |
pmid:6440544
|
Camussi G et al. |
Effect of platelet activating factor on guinea-pig papillary muscle. |
1984 |
Experientia |
pmid:6086382
|
Sills RH |
Thrombotic thrombocytopenic purpura. I. Pathophysiology and clinical manifestations. |
1984 |
Am J Pediatr Hematol Oncol |
pmid:6442830
|
Lartigue-Mattei C et al. |
Pharmacokinetic study of 3H-labelled PAF-acether II. Comparison with 3H-labelled lyso-PAF-acether after intravenous administration in the rabbit and protein binding. |
1984 |
Agents Actions |
pmid:6532184
|
Kulikov VI et al. |
[Incorporation of 1-0-alkyl-2-acetyl-sn-glycerol-3-phosphocholine into human plasma lipoproteins in vitro. Effect of the lecithin:cholesterol acyltransferase activity of plasma]. |
1984 |
Biokhimiia |
pmid:6542803
|
Nagata K et al. |
[Thrombotic thrombocytopenic purpura (TTP) with a remission following splenectomy after the failure of antiplatelet therapy and plasmapheresis]. |
1984 |
Rinsho Ketsueki |
pmid:6542941
|
Pirotzky E et al. |
PAF-acether-induced plasma exudation in rat skin is independent of platelets and neutrophils. |
1984 |
Microcirc Endothelium Lymphatics |
pmid:6546141
|
Bussolino F et al. |
Platelet-activating factor phosphatidate, but not platelet-activating factor, is a powerful calcium ionophore in the human red cell. |
1984 |
Cell Calcium |
pmid:6549153
|
Pirotzky E et al. |
Biosynthesis of platelet-activating factor. VI. Precursor of platelet-activating factor and acetyltransferase activity in isolated rat kidney cells. |
1984 |
Lab. Invest. |
pmid:6492758
|
Smith RJ et al. |
Stimulation of the human neutrophil superoxide anion-generating system with 1-O-hexadecyl/octadecyl-2-acetyl-sn-glyceryl-3- phosphorylcholine. |
1984 |
Biochem. Pharmacol. |
pmid:6324816
|
Buxton DB et al. |
Stimulation of hepatic glycogenolysis by acetylglyceryl ether phosphorylcholine. |
1984 |
J. Biol. Chem. |
pmid:6693418
|
Shukla SD and Hanahan DJ |
Acetylglyceryl ether phosphorylcholine (AGEPC; platelet-activating factor)-induced stimulation of rabbit platelets: correlation between phosphatidic acid level, 45Ca2+ uptake, and [3H]serotonin secretion. |
1984 |
Arch. Biochem. Biophys. |
pmid:6465886
|
Doebber TW et al. |
Platelet activating factor intravenous infusion in rats stimulates vascular lysosomal hydrolase secretion independent of blood neutrophils. |
1984 |
Biochem. Biophys. Res. Commun. |
pmid:6517949
|
Heinrich J and Zimmermann RE |
Compound 48/80 is a potent inhibitor of human platelet aggregation antagonizing the calmodulin-dependent platelet reaction in vitro. |
1984 |
Thromb. Res. |
pmid:6523451
|
Oxholm P et al. |
Lack of evidence for human lymphokines with thrombocyte aggregating activity. An in vitro study. |
1984 |
Allergy |
pmid:6528957
|
Hwang SB et al. |
Effects of nonsteroid antiinflammatory drugs on the specific binding of platelet activating factor to membrane preparations of rabbit platelets. |
1984 |
Thromb. Res. |
pmid:6429890
|
Colditz IG and Movat HZ |
Kinetics of neutrophil accumulation in acute inflammatory lesions induced by chemotaxins and chemotaxinigens. |
1984 |
J. Immunol. |
pmid:6470487
|
Patterson R et al. |
Airway responses to sequential challenges with platelet-activating factor and leukotriene D4 in rhesus monkeys. |
1984 |
J. Lab. Clin. Med. |
pmid:6470563
|
Ludwig JC et al. |
Modulation of platelet-activating factor (PAF) synthesis and release from human polymorphonuclear leukocytes (PMN): role of extracellular Ca2+. |
1984 |
Arch. Biochem. Biophys. |
pmid:6430234
|
Söling HD et al. |
Acetylcholine-like effects of 1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine ('platelet-activating factor') and its analogues in exocrine secretory glands. |
1984 |
Eur. J. Biochem. |
pmid:6207023
|
Pipkorn U et al. |
Effect of platelet activating factor on the human nasal mucosa. |
1984 |
Allergy |
pmid:6703263
|
Lüthje J and Ogilvie A |
Diadenosine triphosphate (Ap3A) mediates human platelet aggregation by liberation of ADP. |
1984 |
Biochem. Biophys. Res. Commun. |
pmid:6704102
|
Clare KA and Scrutton MC |
The role of Ca2+ uptake in the response of human platelets to adrenaline and to 1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine (platelet-activating factor). |
1984 |
Eur. J. Biochem. |
pmid:6705791
|
Kumar R et al. |
A facile route to semi-synthesis of acetyl glycerylether phosphoethanolamine and its choline analogue. |
1984 |
J. Lipid Res. |
pmid:6707528
|
Archer CB et al. |
Synergistic interaction between prostaglandins and PAF-acether in experimental animals and man. |
1984 |
Prostaglandins |
pmid:6203139
|
Schlondorff D et al. |
Effect of platelet-activating factor and serum-treated zymosan on prostaglandin E2 synthesis, arachidonic acid release, and contraction of cultured rat mesangial cells. |
1984 |
J. Clin. Invest. |
pmid:6423667
|
Vargaftig BB et al. |
[Platelet aggregation and PAF-acether. Pharmacologic interference]. |
1984 |
J Pharmacol |
pmid:6374298
|
Ito S et al. |
Hyperacute renal allograft rejection in the rabbit. The role of platelet-activating factor and of cationic proteins derived from polymorphonuclear leukocytes and from platelets. |
1984 |
Lab. Invest. |
pmid:6379289
|
Bult H et al. |
Complement derived factors and prostacyclin formation by rabbit isolated peritoneum and cultured mesothelial cells. |
1984 |
Agents Actions Suppl. |
pmid:6382974
|
Hechtman HB et al. |
Role of humoral mediators in adult respiratory distress syndrome. |
1984 |
Chest |
pmid:6383742
|
Kelton JG et al. |
The detection of a platelet-agglutinating factor in thrombotic thrombocytopenic purpura. |
1984 |
Ann. Intern. Med. |
pmid:6333196
|
Bussolino F et al. |
Release of platelet-activating factor (PAF)-like material from human lymphoid cell lines. |
1984 |
Exp. Hematol. |
pmid:6333353
|
Wodzinowska B and Krajewski T |
[Role of blood platelets and their membrane in the process of hemostasis]. |
1984 Jan-Feb |
Postepy Hig Med Dosw |
pmid:6093087
|
Vemulapalli S et al. |
Cardiovascular and renal action of platelet-activating factor in anesthetized dogs. |
1984 Jul-Aug |
Hypertension |
pmid:6378787
|
Cox CP et al. |
VIP elevates platelet cyclic AMP (cAMP) levels and inhibits in vitro platelet activation induced by platelet-activating factor (PAF). |
1984 Mar-Apr |
Peptides |
pmid:6206481
|
Matsumoto M and Miwa M |
Platelet-activating factor-binding protein in human serum. |
1985 |
Adv. Prostaglandin Thromboxane Leukot. Res. |
pmid:3004155
|
Terashita Z et al. |
Beneficial effects of (RS)-2-methoxy-3-(octadecylcarbamoyloxy)propyl 2-(3-thiazolio)ethyl phosphate, a specific PAF antagonist, in endotoxin and anaphylactic shock. |
1985 |
Adv. Prostaglandin Thromboxane Leukot. Res. |
pmid:3004156
|
Barnes JL and Venkatachalam MA |
The role of platelets and polycationic mediators in glomerular vascular injury. |
1985 |
Semin. Nephrol. |
pmid:2957770
|
Leid RW and Potter KA |
Inflammation and mediators of lung injury. |
1985 |
Vet. Clin. North Am. Food Anim. Pract. |
pmid:3907779
|
Shukla SD |
Platelet activating factor-stimulated formation of inositol triphosphate in platelets and its regulation by various agents including Ca2+, indomethacin, CV-3988, and forskolin. |
1985 |
Arch. Biochem. Biophys. |
pmid:3875314
|
Roubin R and Benveniste J |
Formation of prostaglandins, leukotrienes and paf-acether by macrophages. |
1985 |
Comp. Immunol. Microbiol. Infect. Dis. |
pmid:3910339
|
Billah MM et al. |
Platelet-activating factor metabolism in human amnion and the responses of this tissue to extracellular platelet-activating factor. |
1985 |
Prostaglandins |
pmid:3936121
|
Wasserman SI |
Mast cell mediators in the blood of patients with asthma. |
1985 |
Chest |
pmid:3880526
|
Halonen M et al. |
Participation of platelets in the physiologic alterations of the AGEPC response and of IgE anaphylaxis in the rabbit. Effects of PGI2 inhibition of platelet function. |
1985 |
Am. Rev. Respir. Dis. |
pmid:3881060
|
Sybertz EJ et al. |
Cardiac, coronary and peripheral vascular effects of acetyl glyceryl ether phosphoryl choline in the anesthetized dog. |
1985 |
J. Pharmacol. Exp. Ther. |
pmid:3917504
|
Harlan JM |
Leukocyte-endothelial interactions. |
1985 |
Blood |
pmid:3918593
|
McKean ML and Silver MJ |
Phospholipid biosynthesis in human platelets. The acylation of lyso-platelet-activating factor. |
1985 |
Biochem. J. |
pmid:3919710
|
Archer CB et al. |
Actions of disodium cromoglycate (DSCG) on human skin responses to histamine, codeine and Paf-acether. |
1985 |
Agents Actions |
pmid:3923788
|
Sturk A et al. |
Synergistic effects of platelet-activating factor and other platelet agonists in human platelet aggregation and release: the role of ADP and products of the cyclooxygenase pathway. |
1985 |
Thromb. Res. |
pmid:2934863
|
Morley J et al. |
Pharmacology of the late response to allergen and its relevance to asthma prophylaxis. |
1985 |
Int. Arch. Allergy Appl. Immunol. |
pmid:3924841
|
Lachachi H et al. |
Inhibition of transmembrane movement and metabolism of platelet activating factor (PAF-acether) by a specific antagonist, BN 52021. |
1985 |
Biochem. Biophys. Res. Commun. |
pmid:2998370
|
Hwang SB et al. |
trans-2,5-Bis-(3,4,5-trimethoxyphenyl)tetrahydrofuran. An orally active specific and competitive receptor antagonist of platelet activating factor. |
1985 |
J. Biol. Chem. |
pmid:2999126
|
Camussi G et al. |
The role of platelet-activating factor in experimental immune complex pathology. |
1985 |
Int J Tissue React |
pmid:2932406
|
Benveniste J |
Biosynthesis and function of PAF-acether (platelet-activating factor). |
1985 |
Adv. Prostaglandin Thromboxane Leukot. Res. |
pmid:2936197
|
Waku K et al. |
Metabolism of 1-O-alkyl-2-acyl-sn-glycero-3-phosphocholine: a precursor of platelet-activating factor in macrophages. |
1985 |
Adv. Prostaglandin Thromboxane Leukot. Res. |
pmid:2936199
|
Zimmerman GA et al. |
Production of platelet-activating factor by human vascular endothelial cells: evidence for a requirement for specific agonists and modulation by prostacyclin. |
1985 |
Circulation |
pmid:3928193
|
Valone FH |
Inhibition of binding of the platelet-activating factor AGEPC to platelets by the AGEPC analog rac-3-(N-n-octadecylcarbamoyloxy)-2-methoxypropyl 2-thiazolioethyl phosphate (CV-3988). |
1985 |
Biochem. Biophys. Res. Commun. |
pmid:3970703
|
Camussi G and Brentjens JR |
Inhalation of horseradish peroxidase by rabbits with specific IgE antibodies results in release into the circulation of platelet-activating factor and in lung lesions. |
1985 |
Clin. Immunol. Immunopathol. |
pmid:3971603
|
Darius H et al. |
Beneficial effects of a new potent and specific thromboxane receptor antagonist (SQ-29,548) in vitro and in vivo. |
1985 |
J. Pharmacol. Exp. Ther. |
pmid:2997428
|
Chesney CM et al. |
Desensitization of human platelets by platelet activating factor. |
1985 |
Biochem. Biophys. Res. Commun. |
pmid:3977920
|
Nakayama R et al. |
Generation of acetyl glyceryl ether phosphorylcholine from the rat skin and muscle tissues stimulated by moxibustion. |
1985 |
Biochem. Biophys. Res. Commun. |
pmid:3977939
|
Archer CB et al. |
Accumulation of inflammatory cells in response to intracutaneous platelet activating factor (Paf-acether) in man. |
1985 |
Br. J. Dermatol. |
pmid:3978036
|
Gerdin B et al. |
Permeability-increasing ability of PAF-acether in rat skin. |
1985 |
Inflammation |
pmid:3980073
|
Emeis JJ and Kluft C |
PAF-acether-induced release of tissue-type plasminogen activator from vessel walls. |
1985 |
Blood |
pmid:3924144
|
Benveniste J and Chignard M |
A role for PAF-acether (platelet-activating factor) in platelet-dependent vascular diseases? |
1985 |
Circulation |
pmid:3928192
|
Ludwig JC et al. |
Modulation of platelet-activating factor (PAF) synthesis and release from human polymorphonuclear leukocytes (PMN): role of extracellular albumin. |
1985 |
Arch. Biochem. Biophys. |
pmid:4037794
|
Surles JR et al. |
Facile synthesis of platelet-activating factor and racemic analogues containing unsaturation in the sn-1-alkyl chain. |
1985 |
J. Med. Chem. |
pmid:4038418
|
Aul C et al. |
[Thrombotic thrombocytopenic purpura]. |
1985 |
Klin. Wochenschr. |
pmid:4038757
|
Hanahan DJ et al. |
A novel approach to structure proof of glyceryl ether-containing glycerophospholipids. Base-catalyzed methanolysis of platelet-activating factor (AGEPC) at 60 degrees C. |
1985 |
J. Lipid Res. |
pmid:4067422
|
Atkins JN |
Platelet-aggregating factor in thrombotic thrombocytopenic purpura. |
1985 |
Ann. Intern. Med. |
pmid:4038861
|
Klöcking HP et al. |
Release of tissue-type plasminogen activator by platelet-activating factor. |
1985 |
Thromb. Res. |
pmid:4040278
|
Pedersen AK and FitzGerald GA |
Cyclooxygenase inhibition, platelet function, and metabolite formation during chronic sulfinpyrazone dosing. |
1985 |
Clin. Pharmacol. Ther. |
pmid:3917387
|
McManus LM and Pinckard RN |
Kinetics of acetyl glyceryl ether phosphorylcholine (AGEPC)-induced acute lung alterations in the rabbit. |
1985 |
Am. J. Pathol. |
pmid:4050977
|
Disselnkötter H et al. |
[Synthesis of phosphono analogs of 2-O-acetyl-1-O-hexadecyl(octadecyl)-sn-3-glycerylphosphorylcholine (platelet-activating factor)]. |
1985 |
Arch. Pharm. (Weinheim) |
pmid:4051690
|
Monnens L et al. |
Platelet aggregating factor in the epidemic form of hemolytic-uremic syndrome in childhood. |
1985 |
Clin. Nephrol. |
pmid:4042442
|
Pirotzky E et al. |
Vascular permeability induced by Paf-acether (platelet-activating factor) in the isolated perfused rat kidney. |
1985 |
Agents Actions |
pmid:4003192
|
Page CP et al. |
Platelet activating factor (Paf-acether) may account for late-onset reactions to allergen inhalation. |
1985 |
Agents Actions |
pmid:4003195
|
Page CP et al. |
Suppression of Paf-acether responses: an anti-inflammatory effect of anti-asthma drugs. |
1985 |
Agents Actions |
pmid:4003196
|
Spicer BA et al. |
An investigation of the involvement of platelet activating factor in the non-histamine immediate hypersensitivity reaction in the rat peritoneal cavity. |
1985 |
Agents Actions |
pmid:4003197
|
Sandler RM et al. |
Heparin-induced thrombocytopenia and thrombosis: detection and specificity of a platelet-aggregating IgG. |
1985 |
Am. J. Clin. Pathol. |
pmid:4003343
|
Tencé M et al. |
Ether-phospholipid composition in neutrophils and platelets. |
1985 |
Thromb. Res. |
pmid:4024039
|
Oda M et al. |
Production of platelet-activating factor by washed rabbit platelets. |
1985 |
J. Lipid Res. |
pmid:3934305
|
Tan EL and Snyder F |
Metabolism of platelet activating factor (1-alkyl-2-acetyl-sn-glycero-3-phosphocholine) by capillary endothelial cells isolated from rat epididymal adipose tissue. |
1985 |
Thromb. Res. |
pmid:4024051
|
Weisman SM et al. |
Platelet-activating factor is a potent stimulus for renal prostaglandin synthesis: possible significance in unilateral ureteral obstruction. |
1985 |
J. Pharmacol. Exp. Ther. |
pmid:3862805
|
Grandel KE et al. |
Association of platelet-activating factor with primary acquired cold urticaria. |
1985 |
N. Engl. J. Med. |
pmid:2410790
|
Bussolino F et al. |
Alkyl-ether phosphoglycerides influence calcium fluxes into human endothelial cells. |
1985 |
J. Immunol. |
pmid:2411812
|
Johnson HM and Torres BA |
Mechanism of calcium ionophore A23187-induced priming of bone marrow-derived macrophages for tumor cell killing: relationship to priming by interferon. |
1985 |
Proc. Natl. Acad. Sci. U.S.A. |
pmid:2412225
|
Fjellner B and Hägermark O |
Experimental pruritus evoked by platelet activating factor (PAF-acether) in human skin. |
1985 |
Acta Derm. Venereol. |
pmid:2416164
|
Shen TY et al. |
Characterization of a platelet-activating factor receptor antagonist isolated from haifenteng (Piper futokadsura): specific inhibition of in vitro and in vivo platelet-activating factor-induced effects. |
1985 |
Proc. Natl. Acad. Sci. U.S.A. |
pmid:2983307
|
Avdonin PV and Altukhova IP |
[Blocking with phorbol ester, a protein kinase C activator, of receptor-dependent platelet calcium channels]. |
1985 |
Biokhimiia |
pmid:2416359
|
Pannocchia A and Hardisty RM |
Cyclic AMP inhibits platelet activation independently of its effect on cytosolic free calcium. |
1985 |
Biochem. Biophys. Res. Commun. |
pmid:2983714
|
Avdonin PV et al. |
[Mechanism of increase in Ca2+ level in platelet cytoplasm induced by aggregating factors]. |
1985 |
Biokhimiia |
pmid:3000463
|
Lee TD et al. |
Heterogeneity in mast cell populations. |
1985 |
Clin Immunol Rev |
pmid:2417770
|
Leclercq M et al. |
[Effects of Hymenoptera stings: physiopathology and immunology according to recent literature findings]. |
1985 |
Rev Med Liege |
pmid:2418479
|
Pipili E |
Platelet membrane potential: simultaneous measurement of diSC3(5) fluorescence and optical density. |
1985 |
Thromb. Haemost. |
pmid:2418525
|
Nishihira J et al. |
Purification and characterization of the specific binding protein for platelet activating factor (1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine) from human platelets. |
1985 |
Tohoku J. Exp. Med. |
pmid:3001971
|